B[Israeli Defense Minister Threatens to Attack Hamas Overseas Leaders] September 30th, Israeli Defense Minister Katz stated on September 29, local time, that leaders of the Palestinian Islamic Resistance Movement (Hamas) overseas are also among those targeted by Israel, and Israel will pursue all participants in the attack on Israel on October 7, 2023. Katz threatened in a video statement that none of the "core players" involved in the attack on Israel on October 7, 2023, would "die peacefully." Katz also said that the Israeli army killed the commander of the North Gaza Brigade, the military branch of Hamas, during an operation from the night of the 28th to the early morning of the 29th. Recently, Israel has stepped up its attacks on Palestinian armed personnel in the Gaza Strip. Israeli Prime Minister Benjamin Netanyahu said on the 29th that the Israeli army has killed more than a hundred "terrorists" in the Gaza Strip in recent weeks. B[Huadong Medicine: Phase III study of the innovative GLP-1 target oral small molecule agonist HDM1002 tablets for weight loss obtained positive top-line results] On September 27th, Huadong Medicine (000963.SZ) announced that recently, the company’s wholly-owned subsidiary The Chinese Phase III clinical study (HDM1002-301) of HDM1002 tablets, an oral small molecule GLP-1 receptor agonist independently developed by Sino-US Huadong for weight management in overweight or obese people, has achieved positive top-line results. The study showed that each dose group of HDM1002 tablets achieved all primary endpoints and key secondary endpoints at week 44; the weight loss effect continued with continued treatment, and further declined at week 52, with no weight loss plateau observed; at the same time, significant improvements in multiple cardiovascular and metabolic indicators, a significant reduction in liver fat content, and optimization of body composition were observed; safety and tolerability data were consistent with GLP-1 receptor agonist drugs, and no new safety signals were observed. The company has completed Pre-NDA communication and is about to officially submit a marketing application for HDM1002 tablets for weight management in China. A[Zhang Youxia and Liu Zhenli were expelled from the Party and the Military for serious violations of discipline and law] With the approval of the Central Committee of the Communist Party of China and the Central Military Commission, the Central Military Commission’s Discipline Inspection and Supervision Commission opened a case review and investigation on Zhang Youxia, member of the Political Bureau of the CPC Central Committee and Vice Chairman of the Central Military Commission, and Liu Zhenli, member of the Central Military Commission and former Chief of Staff of the Joint Staff Department of the Central Military Commission. On September 21, the Political Bureau meeting of the CPC Central Committee reviewed and approved the Central Military Commission’s “Report on the Review Results and Handling Opinions on the Zhang Youxia Issue” and “Report on the Review Results and Handling Opinions on the Liu Zhenli Issue.”
After investigation, Zhang Youxia and Liu Zhenli abandoned their original mission, alienated themselves from the Party, lost their Party spirit and principles, crossed the red line and bottom line, seriously violated political disciplines and political rules, formed gangs, were disloyal and dishonest to the Party; seriously violated organizational disciplines, and took advantage of their positions to serve Providing help to others such as job promotions, etc., and accepting huge sums of money; seriously violating integrity disciplines and accepting gifts in violation of regulations; seriously violating work disciplines, failing to fulfill the political responsibility of comprehensively and strictly administering the party; seriously violating life disciplines, and neglecting relatives and staff around them.
Zhang Youxia and Liu Zhenli seriously violated party discipline and were suspected of serious job crimes. Political and economic problems were intertwined. Corruption and wealth coexisted with dereliction of duty. The amount involved was extremely huge, the nature was extremely serious, and the impact was extremely bad. In accordance with the "Regulations on Disciplinary Punishments of the Communist Party of China" and other relevant regulations, after study by the Standing Meeting of the Central Military Commission and reported to the Political Bureau of the CPC Central Committee for review, it was decided to expel Zhang Youxia and Liu Zhenli from the party, terminate their qualifications as representatives of the 20th National Congress of the Party, and transfer suspected criminal issues to the military procuratorate for review and prosecution in accordance with the law. The two people were expelled from the party, which will be ratified when a plenary meeting of the Central Committee is convened. Previously, the Central Military Commission had decided to expel Zhang Youxia and Liu Zhenli from the military.
The serious investigation and punishment of Zhang Youxia and Liu Zhenli fully demonstrates the clear attitude of the Party Central Committee and the Central Military Commission to carry out the anti-corruption struggle to the end. It once again demonstrates the firm stance that there are no restricted areas, full coverage, and zero tolerance for the punishment of corruption. There must be no hiding place for corrupt elements in the military. It is a major achievement of the party and the army in the anti-corruption struggle. It is an important manifestation of the determination and strength of the party and the army. The people's army has undergone revolutionary forging in the anti-corruption struggle, becoming purer, more consolidated, and more powerful in cohesion and combat effectiveness. (CCTV News) B[Ten departments: Expand the scale of the precision diagnosis industry] On September 18, ten departments including the Ministry of Industry and Information Technology issued the "Fifteenth Five-Year Plan for the Development of the Pharmaceutical Industry", which mentioned the expansion of the scale of the precision diagnosis industry. Focus on the development of high-throughput gene sequencing, microfluidics, highly sensitive biological detection and other technologies, promote the integration and upgrading of in vitro diagnosis, medical imaging, pathological diagnosis, molecular diagnosis, multi-omics detection and other fields, and accelerate the industrialization of innovative diagnostic products. Improve the quality control, clinical evaluation and standard system of precision diagnostic products. Promote qualified medical institutions to develop precision diagnosis centers, strengthen cooperation with relevant enterprises, promote the interconnection and sharing of diagnosis and treatment data, accelerate the in-depth integration of precision diagnosis technology with digital health and artificial intelligence, and improve the level of precision diagnosis of rare diseases, tumors, genetic diseases, etc.
— All loaded —
